APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer’s disease pathology
Neuron · 2024-04 · 112 (7) · 1110-1116.e5
DOI: 10.1016/j.neuron.2024.01.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuron, 2024-04. Verfasst von Augustine Chemparathy und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, BLRD VA, NHGRI NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
- Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA; Quantitative Sciences Unit, Department of Medicine, Stanford University, Stanford, CA, USA.
- Geriatric Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, USA.
- Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
- Emory University School of Medicine, Atlanta, GA, USA; Goizueta Alzheimer's Disease Center, Emory University School of Medicine, Atlanta, GA, USA.
- Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
Förderung
- NIA NIH HHS
- BLRD VA
- NHGRI NIH HHS
- NIGMS NIH HHS
- Alzheimer’s Disease Research Center, University of Washington
- H2020 Marie Skłodowska-Curie Actions
- Nancy and Buster Alvord Endowment
- Horizon 2020 Framework Programme
Zitieren
APA
Chemparathy, A., Le Guen, Y., Chen, S., Lee, E. G., Leong, L., Gorzynski, J. E., Jensen, T. D., Ferrasse, A., Xu, G., Xiang, H., Belloy, M. E., Kasireddy, N., Peña-Tauber, A., Williams, K., Stewart, I., Talozzi, L., Wingo, T. S., Lah, J. J., Jayadev, S., …, & Greicius, M. D. (2024). APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer’s disease pathology. Neuron, 112(7), 1110-1116.e5. https://doi.org/10.1016/j.neuron.2024.01.008
Vancouver
Chemparathy A, Le Guen Y, Chen S, Lee EG, Leong L, Gorzynski JE, et al. APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer’s disease pathology. Neuron. 2024;112(7):1110-1116.e5. doi:10.1016/j.neuron.2024.01.008
BibTeX
@article{Chemparathy2024,
author = {Chemparathy, Augustine and Le Guen, Yann and Chen, Sunny and Lee, Eun-Gyung and Leong, Lesley and Gorzynski, John E and Jensen, Tanner D and Ferrasse, Alexis and Xu, Guangxue and Xiang, Hong and Belloy, Michael E and Kasireddy, Nandita and Peña-Tauber, Andrés and Williams, Kennedy and Stewart, Ilaria and Talozzi, Lia and Wingo, Thomas S and Lah, James J and Jayadev, Suman and Hales, Chadwick M and Peskind, Elaine and Child, Daniel D and Roeber, Sigrun and Keene, C Dirk and Cong, Le and Ashley, Euan A and Yu, Chang-En and Greicius, Michael D},
title = {APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer’s disease pathology},
journal = {Neuron},
year = {2024},
volume = {112},
number = {7},
pages = {1110--1116.e5},
doi = {10.1016/j.neuron.2024.01.008}
}
EUVIMED